Abstract
Over the last decade, new topical and systemic antimycotics (imidazole derivatives, triazoles, allylamines, and morpholine derivatives) have come onto the market. They have increased therapeutic possibilities, even though these new drugs are not yet available in every country. A standard treatment that will lead to cure in all cases is not available as yet. Therefore, treatment must take into account a number of factors in order to be successful in the long term.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
